US: BÜHLMANN Quantum Blue® Infliximab is for Research Use Only in the US. Not to be used in diagnostic procedures.
Canada: BÜHLMANN Quantum Blue® Infliximab: Health Canada License: 98838
Rapid, Simple, Accurate Quantitative Results
BÜHLMANN’s Quantum Blue® Product line is designed with an innovative solution based on established lateral flow technology which utilizes highly specific monoclonal antibodies to capture the molecule being measured. Optical densities of test and control lines are detected by the Quantum Blue® Reader and translated into a quantitative result.
The BÜHLMANN Quantum Blue® Infliximab Trough Level Assay is a unique assay in the BÜHLMANN Quantum Blue® Product line. It is the ONLY quantitative rapid test in the market for infliximab that can provide fast, reliable information for infliximab, and correlates well with the standard routine ELISAs for determination of infliximab levels.
- Rapid: 15 min to quantitative results
- Ideal Measuring Range: 0.4- 20 µg/ml range
- Quantum Blue® Trusted routine platform
- Utilizes highly specific monoclonal antibody
- Peer reviewed publications
- Correlates well with standard ELISAs for determination of infliximab